Simplex Trading’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
NA
Simplex Trading's RCEL Position: Q2 2026 in Review
Simplex Trading sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 4 shares — an estimated $17 sold.
Simplex Trading first reported a position in RCEL in Q2 2020 and held it in 16 quarters. The position peaked at $253K in Q2 2022. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.
- Simplex Trading reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 4 Avita Medical shares in Q2 2026, an estimated $17.
- Simplex Trading first reported a position in Avita Medical in Q2 2020 and held it in 16 quarters.
- Simplex Trading's Avita Medical position peaked at $253K in Q2 2022.
- 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.